CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity

Overview of attention for article published in Frontiers in immunology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 44,152 followers.

Fantastic meeting @AAN Summer Conference 2024 🤩 Poster presentation on “CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity” Check out full paper at https://t.co/twBXrc2YCs #aan #aansummerconference #aansummerconference202

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity https://t.co/3ujCWuHWnG

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity https://t.co/4zWuvY7yNf

RT @FrontImmunol: New Research: CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity: Background Purkinje cyt…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.